Loading...
XLON
TLY
Market cap3mUSD
May 15, Last price  
1.45GBP
1D
0.00%
1Q
-78.20%
Jan 2017
-97.27%
Name

Totally PLC

Chart & Performance

D1W1MN
XLON:TLY chart
P/E
—
P/S
2.67
EPS
—
Div Yield, %
—
Shrs. gr., 5y
26.86%
Rev. gr., 5y
6.46%
Revenues
107m
-21.38%
2,698,0002,740,0002,823,0001,836,0001,688,0001,758,0001,882,0001,845,0001,619,000878,000609,000577,0003,977,00021,351,00078,007,000105,948,000113,709,000127,373,000135,696,000106,678,000
Net income
-3m
L
-264,000-372,000-44,000-343,000-1,081,000141,00096,000-149,000-588,000-931,000-342,000-413,000-1,516,000-2,061,000-1,502,000-2,833,000318,0001,081,0001,222,000-3,134,000
CFO
-664k
L-69.56%
-175,000-247,00079,000-114,000-12,000141,00058,000-17,00023,000-911,000-362,000-598,000-2,207,000-3,157,000-1,814,0002,899,0009,214,00011,163,000-2,181,000-664,000
Dividend
Sep 07, 20230.125 GBP/sh

Profile

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland. It operates through Urgent Care, Planned Care, and Insourcing segments. The company offers a range of treatment and advice for musculoskeletal injuries and conditions, such as physiotherapy and podiatry to NHS patients; fitness, and occupational health and ergonomic services to corporate and private clients. It also provides dermatology and referral management services; urgent care services; and clinical health coaching services to educate patients to self-manage their conditions, such as chronic obstructive pulmonary disease; and hospital insourcing services, as well as IT healthcare solutions; and provision for online health and safety risk assessments. The company was incorporated in 1999 and is based in Derby, the United Kingdom.
URL
https://www.totallyplc.com/
IPO date
Jan 31, 2000
Employees
1,668
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑122016‑122015‑12
Income
Revenues
106,678
-21.38%
135,696
6.53%
Cost of revenue
104,802
128,808
Unusual Expense (Income)
NOPBT
1,876
6,888
NOPBT Margin
1.76%
5.08%
Operating Taxes
(731)
562
Tax Rate
8.16%
NOPAT
2,607
6,326
Net income
(3,134)
-356.46%
1,222
13.04%
Dividends
(246)
(1,908)
Dividend yield
2.61%
5.96%
Proceeds from repurchase of equity
45
1,779
BB yield
-0.48%
-5.56%
Debt
Debt current
3,078
2,775
Long-term debt
4,360
3,597
Deferred revenue
140
Other long-term liabilities
12
Net debt
5,097
(51,608)
Cash flow
Cash from operating activities
(664)
(2,181)
CAPEX
(636)
(1,800)
Cash from investing activities
(1,932)
(8,170)
Cash from financing activities
(1,514)
1,491
FCF
8,299
8,450
Balance
Cash
2,341
6,451
Long term investments
51,529
Excess cash
51,195
Stockholders' equity
31,785
35,120
Invested Capital
38,711
3,921
ROIC
12.23%
246.72%
ROCE
4.78%
17.40%
EV
Common stock shares outstanding
196,479
194,074
Price
0.05
-70.91%
0.17
-55.41%
Market cap
9,431
-70.55%
32,022
-53.55%
EV
14,528
(19,586)
EBITDA
6,743
11,137
EV/EBITDA
2.15
Interest
338
321
Interest/NOPBT
18.02%
4.66%